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The genome of virulent strains may possess the ability to mutate by means of antigenic shift and/or 
antigenic drift as well as being resistant to antibiotics with time. The outbreak and spread of these 
virulent diseases including avian influenza (H1N1), severe acute respiratory syndrome (SARS-
Corona virus), cholera (Vibrio cholera), tuberculosis (Mycobacterium tuberculosis), Ebola 
haemorrhagic fever (Ebola Virus) and AIDS (HIV-1) necessitate an urgent attention to develop 
diagnostic protocols and assays for rapid detection and screening. Rapid and accurate detection of 
first cases with certainty will contribute significantly in preventing disease transmission and 
escalation to pandemic levels. As a result, there is a need to develop technologies that can meet the 
heavy demand of an all embedded inexpensive, specific and fast bio-sensing for the detection and 
screening of pathogens in active or latent forms to offer quick diagnosis and early treatments in order 
to avoid disease aggravation and unnecessary late treatment costs. 
Nucleic acid aptamers are short, single-stranded RNA or DNA sequences that can selectively bind to 
specific cellular and biomolecular targets. Aptamers, as new-age bio-affinity probes, have the 
necessary biophysical characteristics for improved pathogen detection. This article seeks to review 
global pandemic situations in relation to advances in pathogen detection systems. It particularly 
discusses aptameric biosensing and establishes application opportunities for effective pandemic 
monitoring. Insights into the application of continuous polymeric supports as the synthetic base for 
















Pandemic is the end result of rapid infectious disease transmissions across communities and nations 
by pathogenic micro-organisms. The transmission of the causative pathogen is mostly vectored 
through the consumption and/or exchange of food, water, air and body fluids. The duration of the 
peak outbreak of a pandemic usually last longer than most public health emergencies (Ryan and 
Glarum, 2008; Thomas and Lavender, 2008). Most of the previous pandemic outbreaks occurred in 
waves with high morbidity and mortality cases separated by months. Although the outcome of the 
next pandemic is unknown, its occurrence and eventual effect are expected to be massive on 
economic, social and healthcare efforts (Ryan and Glarum, 2008). An in-depth epidemiological 
knowledge of disease causing agents and emerging disease pathogens is necessary to combat future 
pandemics. Various researchers have developed effective mechanisms essential to slow infection 
rates by interfering with the mode or medium of transmission(Gao et al., 2013; Lee et al., 2008; 
Sakurai et al., 2014; Wolun-Cholewa et al., 2013; Zhao et al., 2008). Peterson et al. (2001) 
highlighted the significance of improved vaccination and antibiotic therapy in the prevention and 
treatment of diseases. Velusamy et al. (2010) reported on the importance of biosensors in detecting 
pathogenic microbes present in food substances as a fundamental approach to prevent diseases in 
humans. Pike et al. (2010) also discussed the horizontal transmission of pathogenic micro-organisms 
from animals to humans as a major form of threat to human health. Based on the aforementioned 
reports and in conformity with past trends of pandemic diseases and monitoring, it can be inferred 
that an effective approach to mitigate pandemics is the development of enhanced pathogen detection 
systems to prevent the spread of diseases irrespective of the source. Notably, two distinctive groups 
of pathogenic detection techniques have been reported in literature for clinical diagnosis; the 
conventional/traditional cell culture technique and the use of analytical devices (biosensors). The 
traditional methods chiefly rely on specific microbiological and biochemical detection via plated 
cultures. These methods are time consuming and labour intensive, although they are inexpensive and 
can yield both qualitative and quantitative results (Lee et al., 2008; Velusamy et al., 2010). Molecular 
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detection methods in the form of biomarking and biosensing are receiving attention as viable 
replacements to traditional cell plating methods. These methods can be engineered to have optimal 
performance variables such as high sensitivity, reliability, rapidity, specificity and simplicity in use 
(Fukushima et al., 2007; Gracias and McKillip, 2004; Leonard et al., 2003; Velusamy et al., 2010). 
Despite the introduction of molecular biosensing technologies for high sensitivity detection and 
monitoring of pathogenic species, there still exists major drawbacks that hinder applications for 
routine mass monitoring, screening and evaluation exercises.  
Laboratories and clinical centres have adopted molecular detection mechanisms based on polymerase 
chain reaction (PCR) to amplify specific nucleic acid sequences of pathogens for identification. 
Commercially available rapid identification tests use PCR followed by reverse hybridization to 
distinguish between pathogenic species. The technique is faster and more specific than cell colonies 
identification but the cost of these kits for routine use and mass evaluation is prohibitive, and pathogen 
identification can take a couple of days (Green et al., 2009; Nahid et al., 2014). Immunological 
detection using antibodies is also a commonly used advanced technique successfully employed for 
the detection of pathogens. This mechanism has been boosted by the development of hybridoma and 
antibody display technologies (Leonard et al., 2003). Whilst PCR-based techniques offer a higher 
specificity, immunological detection is faster. Nonetheless both techniques do not offer rapid real-
time detection essential for mass evaluation exercises, and as such these technologies are unfit for 
applications requiring almost instantaneous results (Leonard et al., 2003).    
Bioaffinity sensing formats can be used for direct detection of pathogens without the need for prior 
biochemical treatment of the sample. It requires the design of molecular probes with high specificity 
towards target species, and presently, antibodies are the most established probes for bioaffinity 
detection. However, the significant effort required to produce highly specific antibodies towards a 
single target is a major challenge towards the use of antibody probes (Velusamy et al., 2010), and 
this has triggered the need for alternative biomolecular probes. Systematic evolution of ligands by 
exponential enrichment (SELEX), an iterative selection and amplification mechanism, can be used to 
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generate nucleic acid aptamers which are short single-stranded RNA or DNA sequences that can 
selectively bind to specific biomolecular or cellular targets, and have a wide range of biomedical 
applications. Molecular binding occurs via interaction between the target and the 3-D loop structure 
of the aptamer (Guo et al., 2008). Aptamers can be engineered to demonstrate desirable biosensing 
characteristics such as high specificity, rapid detection, high sensitivity, easy to read, non-reactive, 
and high performance under physiological conditions with an infinite spectrum of potential targets 
(Radom et al., 2013; Santosh and Yadava, 2014). Aptamers can retain their binding characteristics 
after immobilisation and can be tagged with different functionalities. Cell-based SELEX, targeting 
whole living cells, can be used to generate specific aptamers with high affinity towards membrane 
receptors or surface proteins, serving as the optimal molecular probe to accurately detect and 
characterise the pathogen at the molecular level (Guo et al., 2008). Thus, this article discusses specific 
applications of aptameric sensing for pathogen detection as an effective approach to mitigating 
pandemics.   
2.0 GLOBAL PANDEMIC OUTBREAK AND MONITORING 
Pandemic diseases are characterised by specific epidemiological features such as wide geographic 
extension, swift disease movement, high attack rates and explosiveness, minimal population 
immunity, novelty, contagiousness and severity (Morens et al., 2009). WHO aims at predicting future 
disease outbreaks before it reaches pandemic levels. This will enable rapid deployment of resources 
to control the spread of the disease. Table I presents a list of past, present and potential pandemic 
diseases. As a result of epidemiological studies and vaccination, some past pandemic diseases, such 
as plague, small pox and typhus, have been mitigated or eradicated. However, pandemic diseases 
such as HIV/AIDS and Cholera are still trending on especially in developing countries. Presently, the 
Department of Pandemic and Epidemic Diseases of the World Health Organisation has identified 16 
diseases as potential pandemic causing diseases of the 21st century. These are Avian influenza, 
Cholera, Plague, Emerging diseases (such as nodding disease), Leptospirosis, Nipah virus infection, 
Viral hepatitis (A, B, C, E), Influenza (seasonal and pandemic), Viral haemorrhagic fevers (such as 
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Ebola, Marburg, Lassa, and Crimean-Congo haemorrhagic fever), Tularaemia, Rift Valley fever, 
SARS and coronavirus infections, Meningitis, yellow fever and Hendra virus infection 
(www.who.int/csr/disease/en/). 
3.0 PATHOGEN DETECTION FOR PANDEMIC MONITORING 
There exists a wide range of known and unknown pathogenic environments by which access to a 
healthy human host emanates on contact. These include water, food, agricultural, clinical samples, 
domestic and wild animals, and these materials are essential in identification and monitoring of any 
pandemic or potentially pandemic diseases. The most common mode of transmission during 
pandemic outbreaks is through contact with body fluids/sites of suspected infected humans and 
aerosols. The detection and identification of emerging or re-emerging pandemic pathogens is crucial 
according to WHO, hence rapid detection and identification of such pathogens will enhance the 
monitoring of pandemic cases since they are inevitable (Morens et al., 2009). Successful detection of 
first cases will help in the identification of the source and mode of transmission.  
The traditional cell culture and colony counting method is regarded as the standard method for 
pathogen detection and identification (Leland and Ginocchio, 2007; Wark et al., 2010). It is 
performed in vitro in a controlled and defined environment through the isolation of cells from the 
tissues of animals or plants, involving a series of fastidious culturing and sub-culturing of 
microorganisms and biochemical recognition. The standard protocol involves a 16mm x 25mm plastic 
or glass round-bottom screw-cap tube for multiple detections (Leland and Ginocchio, 2007), though 
the results can be very slow. Shell vial and microwell plate, on the other hand, are comparatively 
faster (Leland and Ginocchio, 2007). Wolun-Cholewa et al. (2013) reported on the development of a 
novel 3-D cell culture support from Polyaniline nanostructured 3D grids. Halldorsson et al. (2015) 
also discussed the pros and cons of novel microfluidic devices intended to improve the cell culture 
technique. A detailed comparison between various developments in the cell culture technique is 
presented in Table II. With the aforementioned limitations of cell culturing, most clinical laboratories 
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are investing in molecular techniques as the standard methods for pathogen detection for rapid 
diagnosis and prognosis of patients (Hodinka and Kaiser, 2013). 
3.1 Molecular Techniques for Detection and Identification 
The development of molecular techniques are intended to overcome issues relating to the complicated 
growth profile of some pathogenic cells such as mycobacterium tuberculosis; the need to detect 
pathogenic microorganisms with low numbers; and lastly the need to detect emerging and re-
emerging highly infectious micro-organisms (Fawley and Wilcox, 2005). Various kinds of molecular 
diagnostic techniques are in existence. However, the most predominant molecular technique in 
clinical diagnosis for pandemic diseases is the PCR technique. In general, the principle behind 
molecular technique is reliant on the detection, identification, characterization and manipulation of 
specific sequences of nucleotides or unique surface proteins of the pathogen (Wark et al., 2010). The 
selection of an appropriate molecular technique is dependent on the following factors: nature of the 
sample, cost, simplicity in use and the ease of data interpretation (Monis and Giglio, 2006).  
DNA based molecular techniques rely on either the sensing capacity of non-amplified DNA probes 
or through nucleic acid amplification. DNA probes, usually used in diagnostic kits, are designed to 
be complementary to specific nucleic acid sequences of the pathogen under stringent conditions 
(Riahi et al., 2011; Wu et al., 2013). To detect the hybridised nucleic acid probe, reporter molecules 
can be labelled on the probe to exhibit detectable and measurable features. The reporter molecules 
may be enzymatic, chemiluminescent, antibodies or fluorescent dyes (Wu et al., 2013). Some 
established molecular techniques involving the application of non-amplified DNA probes for clinical 
diagnosis are shown in Figure I. 
Nucleic acid amplification techniques (NAAT) are used for in vitro amplification of nucleic acids. 
Various NAAT exist for enhanced detection of pathogens based on their genome. PCR technique 
remains the most commonly used NAAT in research and clinical diagnosis of infectious and 
contagious diseases (She and Marlowe, 2013). PCR technique allows for the detection, identification 
and production of large amounts of specific pathogenic DNAs out of a large array with much rapidity 
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and sensitivity (Garibyan and Avashia, 2013; Loeffelholz and Deng, 2013). The entire in vitro cyclic 
process can be partitioned into three steps involving: (i) denaturing of the pathogenic DNA (ii) 
annealing of the separated DNA strands of the pathogen with the primers at a specified lowered 
temperature, and (iii) elongation of the primers through the addition of nucleotides to the developing 
DNA strand at specified elevated temperatures (Garibyan and Avashia, 2013; Loeffelholz and Deng, 
2013). Various forms of PCR techniques are in existence for the detection of pathogens. These include 
conventional PCR, allele-specific PCR, hot-start PCR, touchdown PCR, degenerate PCR, multiplex 
PCR, nested and heminested PCR, reverse transcription-PCR, quantitative PCR and real-time PCR 
(Loeffelholz and Deng, 2013). 
Herein, features of the various PCR techniques are briefly highlighted. Allele-specific PCR is used 
to detect and identify closely related species of bacteria. Hot-start PCR is used to increase the yield 
of target by reducing the activities of polymerase during the reaction set-up. Degenerate PCR 
enhances the detection of divergent sequences through the use of degenerate primers. Touchdown 
PCR enhances the reduction in the detection of non-specified products. Nested and heminested PCR 
improves sensitivity and specificity though they are associated with high cost and long duration. 
Multiplex PCR are useful for multiple detections of target DNA sequences. Reverse transcriptase-
PCR, a qualitative technique based on the establishment of complementary DNA transcripts of targets 
from their RNAs, is mainly suitable for the diagnosis and prognosis of infectious diseases such as 
tuberculosis, HIV-1, and Avian influenza. Real-time PCR yields simultaneous periodic 
amplifications. Quantitative PCR is ideal for the quantification of nucleic acid targets (Loeffelholz 
and Deng, 2013).  
Major milestones have been achieved in the development and application of PCR techniques for the 
detection of infectious diseases. Huq et al. (2012) reported the importance of sample purification in 
the detection of Vibrio Cholera species although this prolonged the assay time. Sample purification 
was essential for the elimination of organic matters capable of inhibiting amplification (Huq et al., 
2012). Ntema et al. (2010) also reported that pre-enrichment of samples before multiplex PCR (m-
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PCR) improved the sensitivity: 4–10 cfu/100mL compared to 40-100cfu/100mL for non-enriched 
sample of vibrios. Optimal process variables for the application of PCR techniques have been 
developed to detect the pandemic strain Vibrio parahaemolyticus (Myers et al., 2003). For viral 
pathogens, a pan haemagglutinin (PanHA) RT-PCR technique has been developed to identify variant 
influenza sub-types on site using five derived degenerated primers (Gall et al., 2008). Also, an m-
RT-PCR has been developed using a dual priming oligonucleotide system to detect H1N1, H1N2 and 
H3N2 subtypes at a low concentration of 1 TCID50/ml per subtype (Lee et al., 2008). 
The merits of using PCR techniques include rapidity, high sensitivity, several multiple replication of 
trace DNA for qualitative and quantitative analysis (Garibyan and Avashia, 2013; Postollec et al., 
2011), quantification of detected DNA with qPCR (Garibyan and Avashia, 2013), capacity to detect 
viable but non-culturable pathogens (Postollec et al., 2011), provision of information on microbial 
activity especially when qPCR is used in conjunction with reverse transcription (Postollec et al., 
2011), and less labour intensive compared to cell culture techniques. However, a number of 
challenges are faced in the application of PCR technique and this comprises of the potential for the 
inclusion of false results from trace contaminations due to high sensitivity of the technique (Garibyan 
and Avashia, 2013; Wark et al., 2010), and the lack of capacity for applications relating to unknown 
pathogenic species since the technique relies on known data to develop primers (Garibyan and 
Avashia, 2013). This continues to remain a difficulty for the application of this technique to emerging 
and novel infectious pathogens. Also, primers used in PCR can anneal to themselves or to unwanted 
DNAs resulting in a false result (Garibyan and Avashia, 2013). During DNA sequencing, incorrect 
nucleotides can be included by the enzyme at low rates (Garibyan and Avashia, 2013). PCR is a costly 
and complex process thus requires the presence of trained personnel (Velusamy et al., 2010). 
 
3.2 Bioaffinity Techniques 
Bioaffinity techniques that can be deployed in the mitigation and monitoring of pandemic diseases 
are reliant on the use of biomarkers. Biomarkers can be engineered to detect variant pathogens on a 
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molecular level, eliminating the high risk of trial and errors during diagnosis (Soontornworajit and 
Wang, 2011). The capacity for real-time biosensing using bioaffinity techniques is essential for 
pandemic monitoring.  
Antibodies are predominantly used as probes for this technique in clinical diagnosis. A conventional 
method of employing antibodies is through the use of enzyme linked immunosorbent assays (ELISA). 
ELISA involves a series of steps reliant on antibodies-antigens affinity to detect the presence and 
quantity of microbial pathogens in a sample (Lazcka et al., 2007). The antigens in this case are the 
target pathogens of interest, often immobilised in a 96 well plate. However, such techniques do not 
produce the much needed real-time results. On the other hand, immunochromatography assays which 
employ antibodies can be used for rapid detection of specific antigens, and this technique has been 
applied in detecting pandemic strains such as influenza virus (Mitamura et al., 2013; Sakurai et al., 
2014), mycobacterium tuberculosis (Marzouk et al., 2011; Park et al., 2009) and HIV (Sacks et al., 
2012). A fast real-time result, within 15 minutes, has been achieved with immunochromatography. 
Despite successes in using immunochromatography for rapid clinical diagnosis, reports from medical 
experts during and after the 2009 pandemic H1N1 showed low sensitivities within a wide range of 
10% to 70% (Ginocchio, 2011). This has retarded interest in the use of this technique. However, 
improvements in sensitivity by 10 fold have been reported by Sakurai et al. (2014) through the 
labelling of antibodies with coloured NanoAct beads for diagnosis and typing of influenza, and this 
can be adapted and applied to other diseases with pandemic strains for rapid detection (Sakurai et al., 
2014).     
Owing to the inherent limitations of antibodies, setbacks in the area of sensitivity and specificity 
cannot be eliminated totally. Immunoassays are still faced with a number of challenges, albeit an 
improvement over the conventional and molecular techniques (Van Dorst et al., 2010). The 
immobilisation of antibodies in a stable, high density and reproducible manner with no loss in 
bioactivity is very challenging. The significant effort required to produce highly specific antibodies 
towards a single target is another hindrance towards the use of antibody probes (Velusamy et al., 
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2010). There are also ethical issues with the usage of animal parts for inexpensive production of 
polyclonal antibodies. It is impossible to use antibodies as the affinity element to detect cells or 
molecules that are immunogenic or toxic. Polyclonal antibodies are non-specific in their binding to 
specified targets, a challenge which is partially resolved through the use of hybridoma technology, 
though an expensive technique (Van Dorst et al., 2010). Antibody elements cannot be used in austere 
environmental conditions, and are subject to contamination (Van Dorst et al., 2010). These and many 
other challenges have led to the development of aptamer based affinity sensors, some of which have 
been successfully applied in several areas relating to biomedical research and medical applications 
(Radom et al., 2013; Santosh and Yadava, 2014). 
 
4.0 Aptamers as bioprobes 
Aptamers are generated in vitro by means of a robust screening technique termed as SELEX from a 
large pool of synthesised oligonucleotide sequences (Tuerk et al.,1990). The library sequences are 
within the range of 1013-1015(de-los-Santos-Álvarez et al., 2008; Radom et al., 2013; Santosh and 
Yadava, 2014). The screening technique is made up of four systematic steps: variation, selection, 
partition and amplification. The process is repeated sequentially until the oligonucleotide sequence 
with the lowest affinity constant, Kd, binding to the target is selected from the library of 
oligonucleotides (Tuerk et al.,1990). Extensive reviews covering advances and modifications of 
SELEX have been reported previously (Aquino-Jarquin and Toscano-Garibay, 2011; McKeague and 
Derosa, 2012; Stoltenburg et al., 2007). Table III compares the characteristics of aptamer recognition 
elements as biosensing probes with PCR molecular technologies to draw out their similarities and 
comparative advantages. 
 
4.1 Aptamer immobilisation for rapid biosensing 
Immobilisation of aptamers on solid supports is achieved through the chemical modification of its 3’ 
or 5’ end to incorporate functional groups that can enhance bonding to the support (de-los-Santos-
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Álvarez et al., 2008; Toh et al., 2015). The chemistries involved in the immobilisation of aptamers 
on solid supports are reliant on the principles of covalent bonding, adsorption, affinity reactions and 
chemisorption (Bănică, 2012). This supports the development of label free biosensors, thus 
eliminating any interruptions from conjugated markers (de-los-Santos-Álvarez et al., 2008; Xu et al., 
2005). Through immobilisation, aptamers are endowed with the ability for bio-detection as well as 
bioscreening of biomolecular and cellular targets. By virtue of their small size (in the range of 3000-
20000 Da) as compared to antibodies, aptamer immobilisation on polymeric supports leads to a 
reduction in steric hindrance, large surface area coverage, and a high dense surface immobilisation 
for improved throughputs (Deng et al., 2001). Immobilised aptamers can be denatured and 
regenerated continuously, and undergo repeated cycles of denaturing and renaturing (Luzi et al., 
2003; Van Dorst et al., 2010). 
Report by de-los-Santos-Álvarez et al. (2008) showed that the established affinity between aptamers 
and their targets can alter during the immobilisation process. This challenge is, however, suppressed 
through the use of spacers between the aptamer and the surface binding moiety (de-los-Santos-
Álvarez et al., 2008). The advantages of spacers are to help in reducing steric hindrance, maintain the 
shape of the aptamer, increase aptamer-target contact from the surface and minimise non-specific 
adsorption to the surface of the support (Balamurugan et al., 2008; Zheng et al., 2011). Figure II 
shows a spacer-arm linkage between an aptameric ligand and a support system. Examples of spacers 
include: polyethylene glycol (PEG), hexa-ethyloxy-glycol, oligonucleotides, alkyl chains, and 
mercaptoundecanoic acid (Chou et al., 2004; Waybrant et al., 2014; Zheng et al., 2011).  
Surfaces for aptamer immobilisation can be either 2-dimensional or 3-dimensional. Some examples 
of 2-dimensional surfaces include glass slide, poly(methyl methacrylate) substrates and silicon chips, 
whereas 3-dimensional surfaces include magnetic micro-spheres, agarose micro-spheres, silica 
micro-spheres, monoliths and polystyrene micro-spheres. An example of an immobilised aptamer on 
a 2–dimensional surface in a microarray format for pathogen detection is shown in Figure III below.   
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3-dimensional surfaces are more beneficial than 2-dimensional surfaces in terms of enhancing the 
performance of the aptamer after immobilisation. For an equivalent area for both supports, the surface 
area-to-volume ratio is higher for the latter. Owing to this, a conducive environment for aptamer-
target interaction is provided as they are able to move more freely with their 3-D loop structures and 
conformations in the presence of the target (Sinitsyna et al., 2012).  Table IV compares 2-dimensional 
and 3-dimensional surfaces for aptamer immobilisation and biosensing.   
Aptameric sensing using magnetic, agarose and silica micro-spheres have notably been used for 
screening targets such as cocaine and food related toxic compounds with high specificity and 
sensitivity (Chapuis-Hugon et al., 2011; Madru et al., 2011; Madru et al., 2009; Wu et al., 2011). 
Despite the achievement of this great milestone, major drawbacks of this configuration include the 
slow diffusive mass transfer of samples, the small size of the inter-particle space, and the possible 
existence of void fractions. An effective approach could rely on the use of continuous phase 
macroporous polymers, such as monoliths, for high throughput, specific, sensitive and rapid screening 
of pandemic pathogenic (viruses and bacteria) species  (Danquah and Forde, 2008; Jungbauer and 
Hahn, 2008; Podgornik and Krajnc, 2012; Podgornik et al., 2013).  
Justifications to the use of macroporous polymers include: (i) enhanced mode of transfer by 
convective mass transport; (ii) good chemical and mechanical stabilities, pores interconnectivities 
with reduced pressure drop; (iii) ease of pore size control to handle different size of pathogens without 
clogging, retention of immobilised ligand density for continual usage; (iv) and the possible 
miniaturisation to portable sizes to enable the development of rapid diagnostic kits (Chan et al., 2014; 
Danquah et al., 2008; Podgornik et al., 2013; Roberts et al., 2009; Svec, 2010). It has recently been 
reported that monolithic adsorbents have a fast analysis time and can offer high throughput isolation 
and analysis of large protein molecules, DNA, cells, viruses and virus-alike particles in a 
chromatographic context. (Podgornik and Krajnc, 2012; Podgornik et al., 2013). The sample-
containing target is introduced into the monolithic aptasensor by means of a syringe for disk 
adsorbents or by high pressure application for column adsorbents. The high affinity between the 
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aptamer-functionalised adsorbent and the target causes specific binding which can be exploited for 
analytical purposes pathogenic identification, titration, screening via elution using UV, pH or 
conductivity analyses to obtain real time results on a chromatograph. The real-time results evaluate 
the difference in characteristics between the sample-containing target and the target-free sample 
exiting the column (Deng et al., 2012). As the bond system between aptameric ligands and monolithic 
supports is largely covalent (Mallik and Hage, 2006), it enables the retention of aptamers to prevent 
ligand leaching during target elution with chaotropic reagents (Jungbauer and Hahn, 2008). This 
robustness bodes well for prolonged reusability and affordability for extended usage. A schematic of 
the standard procedure for high throughput operation using monolithic aptasensors is shown in in 
Figure IV. In brief, monolithic systems are gradually gaining grounds as appropriate supports for an 
all embedded realistic aptamer-biosensors for high throughput and instantaneous results in different 
configurations based on the above-mentioned features (Brothier and Pichon, 2014; Deng et al., 2012; 
Han et al., 2012; Zhao et al., 2008). A summary of specific milestones covered for the immobilisation 
of aptamers on monoliths for bioseparation and purification applications is also presented in Table V.   
4.2 Mass Screening with Immobilised Aptamer Sensors 
The essence of biomedical screening during pandemics is to detect the presence of pathogens or 
associated biotoxins in people during or before symptomatic stages. It also helps in identifying and 
isolating both human and non-human hosts of the pathogen. Probes used for this purpose should be 
highly sensitive to detect low concentration levels of the pathogen in order to break the chain of 
transmission. Unfortunately, most rapid diagnostic kits are incapable of detecting the presence of 
target pathogens in asymptomatic individuals harbouring low pathogen levels. For instance, during 
the 2009 pandemic H1N1, infrared scanners were used to distinguish between symptomatic and 
asymptomatic individuals (Sakaguchi et al., 2012). However, there were instances where the status 
of asymptomatic patients could not be confirmed after coming into close proximity with infected 
patients. Also, the deployment of rapid diagnostic kits with a sensitivity of 53.5% frequently yielded 
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false results especially in the early days of sample collection from individuals (Sakaguchi et al., 
2012).    
Aptamers with their unique three-dimensional structures, alongside being short and single stranded, 
enable them to bind against an infinite pool of biological targets with much rapidity, sensitivity and 
specificity, differentiating between different types of pandemic strains. Owing to the variation in size 
of targets and number of binding sites, generally two modes of aptamer-target configuration exist. 
These are the single-site binding and dual-site binding (sandwich assay). The latter is displayed by 
targets small in size and the former by targets large in size (Song et al., 2008). Label free signals from 
aptamer-target interactions can be captured through optical, mass sensitive and electrochemical 
means (Song et al., 2008). Sensors developed based on optical signals are noted for their selectivity 
and sensitivity (Arora et al., 2011; Lazcka et al., 2007; Velusamy et al., 2010). Examples of measured 
optical signals include but not limited to reflection, fibre optics, Raman, refraction, dispersion, 
fluorescence, infrared, chemiluminescence, and phosphorescence (Velusamy et al., 2010). However, 
their associated cost and complexity are prohibitive (Lazcka et al., 2007). Electrochemical-based 
aptasensors, like other sensors, can be categorised into amperometric, impedimetric, conductometric 
and potentiometric. They are an easy to use format of sensors and economical, but with poor 
selectivity and sensitivity for pathogen detection (Lazcka et al., 2007). Hence, undesirable for rapid 
detection of pathogens. Aptasensors developed based on the differential change in mass are sensitive, 
specific, less complex, economical and can be made suitable for pathogenic detection. The differential 
mass change that occurs when the aptamer binds to the target is detected by means of piezoelectricity 
generated from an increase in oscillation on the surface of a crystal such as quartz (Velusamy et al., 
2010). For labelled aptasensors, the choice of labels is critical to avoid interference with the binding 
mechanism of the aptamer towards its target (de-los-Santos-Álvarez et al., 2008). 
Tertiary structures of aptamers formed after binding to targets include a hair pin, G-quartet, stem-
bulge, combination, pseudoknot and T-junction structures (de-los-Santos-Álvarez et al., 2008). 
Aptameric binding is characterised by the three dimensional structure of the aptamer and the sequence 
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(Van Dorst et al., 2010). Unlike antibodies, aptamers can be synthesised in vitro towards specific 
targets with an avoidance of batch to batch variations, chemically modified to enhance stability, 
resistant to a wide variety of buffer changes, and can easily distinguish between enantiomers (Van 
Dorst et al., 2010). The benefits of aptamers have heightened research interests in its applications in 
diagnostic devices (de-los-Santos-Álvarez et al., 2008). Aptameric sensing can detect pathogens even 
in their latent state, and samples can be tested without pre-treatment as compared to molecular 
techniques and immunoassays (Lim et al., 2005).  
4.3 An outlook on aptameric sensing for pathogen detection 
The ease by which aptamers bond to their targets gives room for their incorporation in rapid diagnostic 
kits (Minunni et al., 2004). The unique binding features of aptamers imply that they can be used in 
lieu of immunochromatography assay, ELISA and, immunobead assay for rapid detection and 
screening (Minunni et al., 2004; Toh et al., 2015). The application of aptamers as point of care test 
kits with a reported time of below 15 minutes has been successfully developed for influenza A targets 
(Kiilerich-Pedersen et al., 2013). The system works on the principle of variations in impendence 
resulting from the binding between the target and the immobilised aptamer. The technique is also 
highly specific, stable and with detection limit below clinical requirements (Kiilerich-Pedersen et al., 
2013). 
Several other studies have been done and milestones covered in regards to developing aptamer 
sensors for virulent diseases. Rotherham et al. (2012) reported on the use of DNA aptamers for the 
detection of CFP-10.ESAT-6 heterodimer typical with Mycobacterium tuberculosis. Sensitivity and 
specificity levels of 100% and 68.75% were attained using Youden’s index, whereas 35% and 95% 
were obtained using a rule-in cut-point method, respectively (Rotherham et al., 2012). Minunni et al. 
(2004) reported on the feasibility of developing aptasensors in comparisons to immunobased sensors 
to probe HIV-1 TAT protein. Parameters such as specificity, reproducibility and reusability were 
studied by functionalising aptamers on a gold electrode of piezoelectric quartz-crystals. Notably, a 
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vast difference was observed when a non-treated aptamer was compared to a thermally treated 
aptamer prior to immobilisation and interaction with the analyte, HIV-1 TAT protein, yielding an 
average frequency shift from 19± 2Hz to 63±10Hz and a reproducibility, in terms of coefficient of 
variation, from 10% to 16% (Minunni et al., 2004). Ruslinda et al. (2013) demonstrated the potential 
and reusability of a RNA aptamer immobilised on a diamond field effect transistor for the detection 
of real HIV-1 Tat protein samples at concentrations as low as 1nM. A streptavidin DNA aptamer has 
also been studied for the detection of interferon-gamma at an optimised detection limit of 33pM 
(Chang et al., 2012). A bi-functional protein binding aptamer-DNA functionalised on a quantum dot 
has been described by means of Fluorescent Polarisation (FP) for the detection of H1N1 influenza A 
sequences (Zhang et al., 2013). The detection limit for the reported aptamer recognition technique 
was 3.45 nM with a specificity value of about 48FP/mP (Zhang et al., 2013). Wang et al. (2015b) 
reported on the development of a DNA aptamer-based bifunctional bio-nanogate and was validated 
with an H5N1 avian influenza virus as the target in a sample consisting of H1N1, H2N2, H4N8 and 
H7N2 as non-targets. The reported detection limit within an hour for the label free bio-nano gate 
aptasensors was 2-9 HAU without any matrix effect. In addition, a linear predictor equation was 
developed for viral targets (titre range of 2-10 and 2-2 HAU) with high selectivity for the cognate target, 
H5N1(Wang et al., 2015b).  
4.4 Current setbacks in deploying aptamer technologies 
In spite of the superior qualities, aptamers possess as bioaffinity ligands, only little achievements 
have been realised in real-life applications. General insights into the challenges affecting the use of 
aptamers for the development of rapid biosensors are discussed in this section. One of such setbacks 
arises during the SELEX process for the generation of aptamers from oligonucleotides. In brevity, 
the setbacks in the SELEX process include the formation of sequence overlaps; the selection of 
nucleic acid strands with the appropriate orientation after the cyclic amplification step; and the 
possible development of concatamers (Radom et al., 2013). Nevertheless, these challenges can be 
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resolved by means of pre-and/or post-SELEX modification processes (McKeague and Derosa, 2012; 
Radom et al., 2013). 
According to Baird (2010), although significant body of knowledge has been generated from 
academic and research point of view, less is known of aptamers in the mainstream industry by 
practitioners. Current research work is mostly focused on generating aptamers and understanding the 
fundamental binding theories of aptameric binding with limited emphasis on the development of 
aptameric biosensors for real-life application. Furthermore, there is the expected resistance to change 
from the tried and tested antibody assays to aptameric assays despite the reported drawback of the 
later. A PubMed search of the term “aptamer assay” in 2010 revealed 939 articles by Baird (2010) 
but has increased exponentially to over 2600 as at present. Yet the situation has not drastically 
changed for real-life application in detecting pathogens. Consequently, there is no real-life application 
of aptameric technologies for any of the recent severe epidemics and pandemics over the past decade 
despite the general increase in aptamer research. Research covering aptamer application has largely 
been geared towards thrombin assays, possibly due to the ease of generation and availability of the 
thrombin aptamer. This has been tagged as the “thrombin problem” by researchers (Baird, 2010).  
There is currently no approved standard for the application of aptamers for virulent and pandemic 
strains of pathogens, and this is a major hindrance to the development and routinized application of 
aptameric technologies for pathogen detection. However, Pegaptanib aptamer, though not related to 
pathogenic species, has received FDA approval, with a host of other aptamers under clinical trials for 
specific applications (Anthony et al., 2010; Santosh and Yadava, 2014). 
Wang et al. (2015a) highlighted that most aptasensors are faced with the challenge of reusability for 
more than 15 times stemming from improper immobilisation and regeneration protocols which leads 
to skewed orientation and loss of binding sites. Nevertheless, recently developed aptamer-based 
evanescent wave all-fiber biosensors on 3-D magnetic beads have been demonstrated to encompass 
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the propensity of being reused for more than 300 times whiles maintaining acceptable sensitivities 
(Wang et al., 2015a). 
4.5 Economic Viability of Aptamer Technologies 
With conventional pathogen detection assays such as cell culture and molecular detection challenged 
with contamination, cost, delayed and false results, the use of aptameric sensing has become 
promising considering the technological and socio-economic benefits. The in vitro generation and 
specificity of aptamers alongside the ability to detect latent pandemic pathogens and immunogenic 
targets enable sustained use of aptamers for pathogenic detection. The use of polymerase chain 
reaction to produce aptamers with high reusability potential whiles maintaining their efficacy (Baird, 
2010; Wang et al., 2015a) indicates their suitability for rapid mitigation of pandemic pathogens at an 
affordable cost. The analysis and turn-around time involved with the deployment of aptamer 
technologies is significantly less compared to antibodies (Chen and Yang, 2015), and can be used 
without sample preparations and pre-culturing steps. It is expected that the global market value of 
aptamers may increase to about $2.1 billion dollars with an increase in the number of companies 
involved in the commerce by 2018 (http://www.marketsandmarkets.com/PressReleases/aptamers-
technology.asp). This will potentially lead to a further drop in the cost of aptamer technologies as 
competition arises to make them more affordable. 
5.0 Conclusion 
Bearing the fact that pandemics and severe outbreaks are inevitable, with detrimental effects on every 
aspects of the society, there is an urgent need to invest into technologies that are effective and 
affordable.  
Research advances in the application of aptamer technologies demonstrate that rapid detection of 
disease pathogens with much specificity, sensitivity, reproducible results and low detection limits can 
be achieved. Aptameric sensing can be used for pathogenic screening at entry and exit points of 
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geographical territories to curtail transmission between two locations. It can be applied not only for 
epidemic and pandemic diseases but also for endemic diseases.  
A major drawback to the full scale application of aptamer technologies lies in the standardization and 
acceptance of aptameric sensing protocols as a more versatile, specific and efficient technology to 
replace and/or complement molecular techniques, immunoassays, and phenotypic methods of 
detecting pathogen in clinical samples. In addition, generation of effective chemistries on3-D 
supports in-lieu of the notable 2-D supports for aptamer immobilisation will further enhance target 
detection, reduce sample volume and cost, increase throughput, and promote the design of portable 
kits for domestic pathogen detection during pandemics. Extensive biophysical studies of the support-
aptamer-target interactions are also required to achieve this endeavour. 
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Fig 1 This figure shows the general trend in developing rapid techniques for pathogen detection from 
cell cultures to aptameric recognition  
Fig. 2 Illustration of spacer applications between modified-aptamer and the moiety of the adsorbent 
matrix to offer a better aptamer positioning for effective target interactions 
Fig 3 Illustration of a microarray system using a 2-D coated substrate with immobilised aptamers  
Fig 4 A continuous stationary phase with immobilised aptamers for rapid sensing and convective 
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Table I. Past, present and potential pandemic diseases  
Classification Pathogens with known 
pandemic strains 





Variola major and 
Variola minor 
1 Named pathogen 
associated with 
Small Pox. Totally 
Eradicated in 1979. 
Rickettsia bacteria 1 Causative agent for 
Typhus. It is 
believed to have 
been eradicated but 
there are reported 
cases currently 
with different 
emerging strains of 
the bacteria 
(Edouard et al., 
2014) 
H3N2 1 Eradicated with no 
recorded outbreak 
presently  
H1N1 3 The virus continues 
to emerge from 
zoonotic sources  
H2N2 1 Eradicated with no 
recorded outbreak 
presently  
M. Tuberculosis 1 No longer a 
pandemic disease 
but possesses a 
high infection and 
mortality rate.  
Plague bacillus (Yersinia 
pestis) 
3 The plague disease 







dominant in Africa 
with potential 
higher number of 
infections 






HIV-1 1 The pandemic 
strain HIV-1 is still 
in transmission 
without cure. 
Vibrio Cholera 7 The seventh 
pandemic strain is 
still in transmission 
with reported 
epidemic outbreaks 
in some developing 
countries. 
Ebola Viral  According to the 
WHO, the worst 
epidemic form of 
EBOLA is still 
trending on in 
West Africa with a 
few scattered cases 
in other continents, 
and fears of it 
mutating if active 
measures are not 
put into effect. 
Current average 






 Resulting from 
possible viral 
mutation and the 
current resistance 










Table II. Characteristics of various cell culture technologies to enhance pathogen detection. 
Cell culture 
supports 
Advantages Disadvantages Reference(s) 
Traditional ware Can be used for multiple 
detections, proliferations 




expertise; culturing of 
pathogens is time and 
labour intensive; viable 
but non-culturable cells, 
such as for vibrio 
cholera species, will 
yield false results; 
costly; requires huge 






Velusamy et al., 
2010) 
Shell vial Faster detection than 
traditional ware; viral 
proliferations are used in 
taking diagnostic 
decisions; excellent 




expertise; culturing of 
pathogens is time and 
labour intensive; viable 
but non-culturable cells, 
such as for vibrio 
cholera species, will 
yield false results; 
costly; requires huge 
infrastructure set up 





Velusamy et al., 
2010) 
Microtiter plate A more rapid detection 
than traditional ware; 
viral proliferations are 
utilised in diagnostic 





culturing of pathogens is 
time and labour 
intensive; viable but 
non-culturable cells will 
yield false results; 
costly; require huge 
infrastructure set up 
during pandemics; and 
lacks real time output. 
(Leland and 
Ginocchio, 2007, 




Real time cell division 
imaging with high 
resolution; automatic 
plating of cells culturing, 
harvesting and 
No standard protocol 
exists yet; requires 
technical expertise; long 
duration to obtain 
confirmed results due to 




replenishing processes;  
capable of mimicking the 
natural environment of 
cells; temperature stable  
micro-environment; high 
throughput; does not 
require highly expensive 
incubators; and less 
intake of reagents. 





Relatively high surface to 
volume ratio; can 
withstand overcrowding 
growth load of culture; 
transparent scaffolds for 
real time observation; 
standard fluorescence or 
colorimetric methods can 
be employed for 
evaluation of cells; and 
the support can be 
embedded in in situ 
conditions for ultra-
structural studies.  
Requires technical 
expertise; long duration 
to get confirmed results 
due to sample 
preparation, slow 
growth rate of some 
organisms and 
incubation; and cannot 
be used to study viable 
but non-culturable cells. 
(Wolun-Cholewa 


















Table III. Juxtaposition of PCR and aptamer recognition technologies.  







Mostly natural nucleic 
acids 
Synthetic nucleic acids  
Target Space Has a limited number 
of targets (Unable to 
detect protein toxins 
and non-nucleic acid 
targets)  
Can be generated for an 
almost unlimited number 
of targets  
(Lim et al., 2005, 
Radom et al., 2013) 
 
Nucleic acid 
characterisation   
Highly susceptible to 
contamination  
Less susceptible (Garibyan and 
Avashia, 2013, 




Compulsory Not essential (Wark et al., 2010, 
Lim et al., 2005) 
Rapidity Fast but not comparable 
to aptamers 
Rapid and real time  (Leonard et al., 
2003, Garibyan and 
Avashia, 2013) 
Economics Costly Less costly (Velusamy et al., 
2010, Santosh and 
Yadava, 2014) 
Specificity High High  (Wark et al., 2010) 
Sensitivity High High (Garibyan and 
Avashia, 2013, Yang 
and Rothman, 2004) 




Assay Label dependent Optional depending on 
the format 
(Wark et al., 2010, 
de-los-Santos-
Álvarez et al., 2008) 
Complexity Requires trained 
technicians 
Not required depending 
on the format 
(Velusamy et al., 




Point-of-care Applicable Applicable (Baron and 
Campbell, 2013, 
Cass and Zhang, 
2011) 
Food and Drugs 
Authority 
protocols 
Standard protocols set 
in place for numerous 
targets, especially 
infectious pathogens 
No standard protocols 
have been set in place yet 
except for the macugen 
aptamer 
(Yang and Rothman, 

























 Table IV. Comparison between 3-dimensional and 2-dimensional surfaces for immobilised 
aptameric biosensing.   
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Parameter 2-dimensional 3-dimensional 
Loading 
capacity 
Has a low loading capacity Has a high loading capacity 
Steric 
Hindrance 
Highly susceptible to steric hindrance 
from adjacent aptamers due to low 
loading capacity 
Less susceptible to steric 
hindrance due to high loading 
capacity 
Assay Comparably slow assay development Quick assay development, a 
criterion of importance for 
pandemic application  
Multiplexing Can be used for multiplex assay  Highly efficient for multiplexing 
Economics Less economical Highly economical  
Sensing 
ability 
Can be used only for detection   Can be used for both detection and 
adsorption of pathogens into the 
support matrix  




Table V. Milestones covered for the application of aptamer-immobilised monoliths for bio-separation and purification  
  **Glycidyl methacrylate (GMA); trimethylolpropanetrimethacrylate (TRIM); Poly Ethylene Glycol Dimethacrylate (PEGDA)


















For the separation of cytochrome 
c and thrombin from a sample of 
mixed biomolecules  










Selective enrichment of 
thrombin in complex biological 
fluids 








Selective screening of lysozyme 
(lys) from chicken egg white 











Real-time florescent detection 
and separation of thrombin 
binding to an immobilised 
characterised aptamer in a 
complex mixture of 
biomolecules 





DNA  aptamer Monolithic 
capillary 
column 
Selective extraction of 
Ochratoxin A from beer samples 
mixed with a binding buffer 
6.27 nmol/μL ~9.91 (Brothier and 
Pichon, 2014) 
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